MarketResearch.com logo

Recent Cancer Treatment Research for December 2024


Metastatic triple-negative breast cancer (mTNBC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Women's Health, Oncology/Hematology
Non-Muscle Invasive Bladder Cancer (NMIBC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
Relapsed/Refractory Multiple Myeloma (RRMM) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
Bowen's Disease - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
Natural Killer (NK)-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Marginal Zone Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Metastatic Merkel Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
Osteosarcoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
Acute Myeloid Leukemia (AML) - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Multiple Myeloma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
Prostate cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
Synovial sarcoma (SS) - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
Peripheral T cell Lymphoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Cancer Cachexia (CC)– Epidemiology Forecast—2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast–2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
Metastatic Colorectal Cancer Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology
Metastatic triple-negative breast cancer (mTNBC) - Epidemiology Forecast - 2032
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2022
Topics: Cancer Treatment, Oncology/Hematology
NK Cell therapies - Pipeline Insight, 2022
Topics: Cancer Treatment, Drug Discovery
Lymphoedema - Market Insights, Competitive Landscape and Market Forecast–2026
Topics: Pain, Cancer Treatment, Drug Discovery
Radiologic Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026
Topics: Cancer Treatment, Oncology/Hematology
2022-2026 Europe Cancer Diagnostics Market Opportunities for Major Tumor Markers for Major Tumor Markers: A 38-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipelin
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Europe
2022-2026 Middle East Cancer Diagnostics Market Opportunities for Major Tumor Markers: An 11-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opport
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Middle East
2022-2026 North America Cancer Diagnostics Market Opportunities for Major Tumor Markers: US, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportun
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
2022-2026 Asia-Pacific Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 18 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Asia, Oceania
2022-2026 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 38 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Europe
2022-2026 North America Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - USA, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, T
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
2022-2026 Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - USA, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and O
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Japan, United States, Europe, Global
2022-2026 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - France, German, Italy, Spain, UK - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprot
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
2022-2026 France Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Te
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: France
2022-2026 Germany Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest T
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Germany
2022-2026 Italy Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Italy
2022-2026 Australia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Australia
2022-2026 China Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: China
2022-2026 Russia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Te
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Russia
Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis
Topics: Cancer Treatment, COVID-19/Coronavirus, Respiratory/Pulmonary, Oncology/Hematology
Regions: Global
Nasal Cannula Market, by Product Type (Curved prong cannula, Flared prong cannula, Straight prong cannula, Curved and flared prong cannula) by Material (Plastic, Silicon ) by Application (Asthma, Lung cancer, Chronic bronchitis, Pulmonary embolism, COPD,
Topics: Asthma, Cancer Treatment, Hospitals & Clinics, Long-Term Care, Equipment & Supplies, Respiratory Devices, Respiratory/Pulmonary
Regions: Asia, Europe, Middle East, Oceania
Thymus Cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Thyroid Cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Peripheral T-Cell Lymphoma (PTCL) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Cancer Treatment, COVID-19/Coronavirus, Endoscopy, Computed Tomography (CT), Oncology/Hematology
Gallbladder Cancer - Global Clinical Trials Review, H2, 2021
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
Regions: Global
Global Platinum Based Cancer Drug Market - 2021-2028
Topics: Cancer Treatment, Platinum, Oncology/Hematology
Regions: Global
2022-2026 North America Immunodiagnostic Analyzers and Reagents - USA, Canada, Mexico - Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special
Topics: Instrumentation & Equipment, Cancer Treatment, Immunoassays, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
2022-2026 Canada Immunodiagnostic Analyzers and Reagents - Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Immunoassays, Oncology/Hematology
Regions: Canada
Platinum-Resistant Relapsed Ovarian Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Women's Health, Oncology/Hematology, Obstetrics/Gynecology, Reproductive Health
Injectable Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Biologics, Cancer Treatment, COVID-19/Coronavirus, Needles, Syringes, IV Access, Cardiovascular, Cancer Vaccines, Pandemic Vaccines


Prev  | 54  | 55  | 56  | 57  | 58  | 59  | 60  | 61  | 62  | 63  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.